3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
11
Thoracic
5
Gastrointestinal
5
Other
3
Lymphoid
3
Gynecologic
2
Genitourinary
2
CNS
2
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Dermatologic
1
Classical hematology
1
Conditions
Multiple Myeloma
927
Lymphoma
112
Recurrence
94
Neoplasms, Plasma Cell
92
Lymphoma, Non-Hodgkin
67
Immunoglobulin Light-chain Amyloidosis
60
Hematologic Neoplasms
60
Neoplasms
54
Smoldering Multiple Myeloma
51
Leukemia, Myeloid, Acute
51
Leukemia
51
Myelodysplastic Syndromes
47
Leukemia, Lymphocytic, Chronic, B-Cell
45
Precursor Cell Lymphoblastic Leukemia-Lymphoma
38
Hodgkin Disease
37
Leukemia, Plasma Cell
26
Myeloproliferative Disorders
24
Monoclonal Gammopathy of Undetermined Significance
23
Lymphoma, Large B-Cell, Diffuse
23
Lymphoma, Mantle-Cell
22
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
22
Breast Neoplasms
22
Amyloidosis
22
Primary Myelofibrosis
21
Lymphoma, Follicular
21
Waldenstrom Macroglobulinemia
20
Ovarian Neoplasms
18
Lymphoma, B-Cell, Marginal Zone
17
Lymphoma, B-Cell
17
Colorectal Neoplasms
16
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Inflammation
×
Plasma cell
×
1 year
×
Clear all
NCT07268846
2025-12-08
POSBIO-CRC
AC Camargo Cancer Center
Phase NA
Recruiting
164 enrolled